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Abstract
Background: Budded baculoviruses are utilized for vaccine, the production of antibody and
functional analysis of transmembrane proteins. In this study, we tried to produce and purify the
recombinant Bombyx mori nucleopolyhedrovirus (rBmNPV-hPRR) that displayed human (pro)renin
receptor (hPRR) connected with FLAG peptide sequence on its own surface. These particles were
used for further binding analysis of hPRR to human prorenin. The rBmNPV-hPRR was produced in
silkworm larvae and purified from its hemolymph using size exclusion chromatography (SEC).
Results: A rapid method of BmNPV titer determination in hemolymph was performed using
quantitative real-time PCR (Q-PCR). A correlation coefficient of BmNPV determination between
end-point dilution and Q-PCR methods was found to be 0.99. rBmNPV-hPRR bacmid-injected
silkworm larvae produced recombinant baculovirus of 1.31 × 108 plaque forming unit (pfu) in
hemolymph, which was 2.8 × 104 times higher than transfection solution in Bm5 cells. Its
purification yield by Sephacryl S-1000 SF column chromatography was 264 fold from larval
hemolymph at 4 days post-injection (p.i.), but 35 or 39 fold at 4.5 or 5 days p.i., respectively. Protein
patterns of rBmNPV-hPRR purified at 4 and 5 days were the same and ratio of envelope proteins
(76, 45 and 35 kDa) to VP39, one of nucleocapsid proteins, increased at 5 days p.i. hPRR was
detected in only purified rBmNPV-hPRR at 5 days p.i..
Conclusion: The successful purification of rBmNPV-hPRR indicates that baculovirus production
using silkworm larvae and its purification from hemolymph by Sephacryl S-1000 SF column
chromatography can provide an economical approach in obtaining the purified BmNPV stocks with
high titer for large-scale production of hPRR. Also, it can be utilized for further binding analysis and
screening of inhibitors of hPRR.
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Background
Baculoviruses are large enveloped viruses with double-
stranded circular DNA genomes and have been used for
various biotechnological applications. Baculoviruses are
utilized for the high level production of recombinant pro-
teins in insect cells [1,2] and the gene transduction to
mammalian cells both in vivo and in vitro as a foreign gene
delivery vectors [3-5]. Moreover, budded baculoviruses
are applied for displaying the recombinant proteins on
their surface for antibody production, functional analysis
of receptors and vaccine production [5-7]. More recently,
an increasing number of investigators have challenged the
use of baculovirus for gene therapy applications [8]. The
preparation of modified baculovirus vectors which are
able to direct gene expression in mammalian cells repre-
sents a safer alternative over classical mammalian viruses.
In order to use baculoviruses in gene therapy, the develop-
ment of efficient production process towards high-titer
preparation is required, because of low baculovirus trans-
duction efficiency in mammalian cells compared to other
viral delivery system, e.g. retroviruses.
Autographa californica multiple nucleopolyhedrovirus
(AcMNPV) and Bombyx mori nucleopolyhedrovirus
(BmNPV) have been used in baculovirus expression sys-
tem. BmNPV especially infects silkworm larvae and has
been used for large-scale production of recombinant pro-
tein economically because there is no necessity for cell
cultivation [9-11]. Moreover, it is very difficult to cultivate
Bm cells with a suspension culture and amplify BmNPV in
Bm5 cell culture. The hemolymph of baculovirus-infected
silkworm larvae is used as a high titer-baculovirus solu-
tion. For medical or biological uses, baculovirus purifica-
tion using cation-exchange chromatography [12], size
exclusion chromatography (SEC) [13], and ion-exchange
membrane chromatography [14] from insect cell culture
supernatant have been reported until now. But to date, the
purification of baculovirus from silkworm larval hemol-
ymph has neither been performed nor reported.
In this study, rBmNPV-hPRR, which displays a native
form of human prorenin receptor (hPRR) with FLAG pep-
tide sequence behind its signal peptide sequence on its
own surface [15], was produced in silkworm larval hemo-
lymph; purified by ultracentrifugation and two different
types of SEC. In addition, the rapid method of BmNPV
titer measurement was established using quantitative real-
time PCR (Q-PCR). This is the first report of recombinant
protein-displayed BmNPV purified from silkworm larval
hemolymph by purification with the help of SEC.
Results
Establishment of BmNPV titer measurement by Q-PCR
Until now, plaque assay [16], end-point dilution method
[17] and antibody-based assay [18] have been known as
titer determination method for baculoviruses. The anti-
body-based assay allows the time reduction required for
baculovirus titer, but the antibody for a baculovirus-spe-
cific protein, DNA-Binding Protein (DBP) which is expen-
sive is mandatory. Recently, the plotting of cross points
for individual baculovirus DNA dilution measured by Q-
PCR and titer determination by end-point dilution
method has a precise linear correlation with baculovirus
titer [19]. Therefore, at the first stage of experiments, it was
uncertain whether Q-PCR can be applied to BmNPV.
To apply the Q-PCR on BmNPV titer determination, 142
bp DNA fragment of BmNPV was amplified at the same
position, as done for 142 bp DNA fragment of AcMNPV,
upstream of ie-1 gene. These two DNA fragments have
approximately 95.8% sequence identity. Recombinant
BmNPV-CP-/bx-GGT2 stock [15], whose titer was deter-
mined by end-point dilution method, was diluted and its
baculovirus DNA was extracted from each diluted baculo-
virus DNA solution by High Pure Viral Nucleic Acid Kit
(Roche Diagnostics K. K.). The cross point for each elute,
containing baculovirus DNA, was determined by Q-PCR.
As the number of cycle increased, the fluorescent intensity
increased in all samples except for a negative control (Fig-
ure 1A). No DNA amplification was observed for negative
control containing 6 μl of water instead of baculovirus
DNA. The melting curves of amplified DNA fragment by
Q-PCR were analyzed. Single peaks were observed at
approximately 82°C, indicating that DNA fragments were
amplified specifically by forward and reverse primers
without any unspecific binding (Figure 1B). Standard cal-
ibration curve of cross points vs. virus titer is shown in Fig-
ure 1C. This result confirms that corresponding cross
points and determined titers were correlated linearly with
a correlation efficiency of 0.99. On 2% agarose gel, DNA
fragment at between 100 and 200 bp markers was found
without any other bands (Figure 1D).
Comparison of baculovirus production using between Bm5 
cells and silkworm larvae
For protein expression in Bm5 cells, recombinant BmNPV
was prepared by transfection of recombinant BmNPV bac-
mid DNA into Bm5 cells. Following transfection, BmNPV
is required to be amplified several times in order to obtain
sufficient virus titer for protein expression. Moreover,
time to amplify BmNPV is required due to slow growth
rate of Bm cells compared to Sf-9 cells.
Transfection solution was prepared using 13.6 μg of rBm-
NPV-hPRR bacmid including helper plasmid. Five millili-
ter of transfection solution was obtained from 2.5 × 106
Bm5 cells with cultivation after 6 days post-transfection.
Hemolymph was also prepared from 13.6 μg of rBmNPV-
hPRR bacmid (including helper plasmid)-injected silk-
worm larva. Approximately 0.55 ml of hemolymph wasBMC Biotechnology 2009, 9:55 http://www.biomedcentral.com/1472-6750/9/55
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Q-PCR analysis of BmNPV-CP--/bx-GGT2 Figure 1
Q-PCR analysis of BmNPV-CP--/bx-GGT2. (A) The graph of fluorescent signals during Q-PCR cycles using various bacu-
lovirus stocks. (B) Melting curve analysis of Q-PCR products. Symbols in A and B: dotted lines, water; open circles, 4.9 × 104 
pfu/ml; closed squares, 9.8 × 104 pfu/ml: closed triangles, 4.9 × 105 pfu/ml; closed circles, 4.9 × 105 pfu/ml; open squares, 9 × 105 
pfu/ml. (C) Standard calibration curve of cross point vs. log (BmNPV-CP-/bx-GGT2 titer). (D) Analysis of Q-PCR products 
using BmNPV-CP-/bx-GGT2 stock solution by 2% agarose gel. Lane M: 100-bp ladder DNA marker, lane 1: stock solution of 
9.80 × 105 pfu/ml, lane 2: stock solution of 9.80 × 106 pfu/ml.
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Table 1: Titer determination of transfection solution and hemolymph from a silkworm larva injected with rBmNPV-hPRR bacmid
Volume (ml) Titer (pfu/ml) Baculovirus number (pfu)
Transfection solution 5 9.34E+02 4.67E+03
Hemolymph 0.55 2.38E+08 1.31E+08BMC Biotechnology 2009, 9:55 http://www.biomedcentral.com/1472-6750/9/55
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obtained from a silkworm larva at 6 days p.i. of rBmNPV-
hPRR bacmid. Baculovirus titers of transfection solution
and BmNPV-infected silkworm larval hemolymph were
measured by Q-PCR (Table 1). Titers of transfection solu-
tion and hemolymph were 9.34 × 102 and 2.38 × 108 pfu/
ml, whereas the total baculovirus numbers were 4.67 ×
103  and 1.31 × 108 pfu, respectively. The baculovirus
number from hemolymph was 2.8 × 104 times higher
than that obtained from transfection solution in spite of
the use of the same amount of rBmNPV-hPRR bacmid.
Baculovirus titer in larval hemolymph from rBmNPV-
hPRR-infected silkworm larvae
It was previously reported that baculovirus-infected silk-
worm larval hemolymph was infectious to silkworm lar-
vae [20]. Thirty μl of rBmNPV-hPRR solutions (2.38 × 107,
2.38 × 105, 2.38 × 103 pfu/ml) were injected into silk-
worm larvae, followed by measuring the baculovirus titer
after 4 or 5 days post-injection (p.i.). Surprisingly, 72 pfu/
larva (30 μl of rBmNPV-hPRR solution containing 2.38 ×
103 pfu/ml) was enough to infect all silkworm larvae.
Even the 1:105-diluted hemolymph was still found to be
infectious to silkworm larvae. When 30 μl of 2.38 × 107
pfu/ml rBmNPV-hPRR (7.2 × 103 pfu/larva) was injected,
the highest baculovirus titer (4.50 × 109 pfu/ml) was
obtained for 5 days breeding (Figure 2A). The volume of
hemolymph from silkworm larvae injected with 2.38 ×
107 pfu/ml (7.2 × 105 pfu/larva) at 4 days breeding was
similar, but at 5 days breeding it was only one third or one
quarter of hemolymph. Therefore, when 2.38 × 105 pfu/
ml baculovirus solution was injected, total baculovirus
number in hemolymph was found to be the highest (9.45
× 108 pfu/larva) (Figure 2B).
Purification of rBmNPV-hPRR from silkworm larval 
hemolymph using size exclusion chromatography
Hemolymph was harvested from rBmNPV-hPRR contain-
ing hemolymph (approximately 105 pfu/ml)-injected silk-
worm larvae at 4 days p.i. and centrifuged at 20000 × g to
remove insoluble materials. The supernatant was recov-
ered and centrifuged at 114000 × g in 25% sucrose cush-
ion. The pellet contained a large amount of dark-
brownish materials that were hard and insoluble (data
not shown). This dark-brownish pellet was obviously dif-
ferent from translucent white baculovirus pellets. In order
to remove insoluble substances, the hemolymph was cen-
trifuged again at 20000 × g and filtered using 0.2 μm
membrane filters. This filtrate was centrifuged at 114000
× g in 25% sucrose cushion, but still the dark-brownish
pellets were visible.
Superdex 200 10/300 GL column was used for purifica-
tion of rBmNPV-hPRR from larval hemolymph. Larval
hemolymph was filtered with 0.2 μm membrane filter,
and 2.38 × 108 pfu/ml rBmNPV-hPRR was obtained. Five
hundred μl of the filtrate was applied upon Superdex 200
10/300 GL column equilibrated with PBS. Elution was
performed by PBS and every 0.5 ml was collected. Its chro-
matogram is shown in Figure 3A. The first peak was eluted
between 6.5 and 8.5 ml in the void volume, and GP64 was
detected in the first peak fractions (Fraction 14, 15 in Fig-
ure 3A). Maximum baculovirus titer was 4.86 × 107 pfu
(Figure 3B) at the fraction 14 and the total number of
recovered rBmNPV-hPRR was 1.21 × 108 pfu with recovery
ratio of 100% (Table 2). It suggested that there is no loss
of BmNPV at this purification step. However the concen-
tration of the virus was done by ultracentrifugation, and
its recovery decreased by 30% (Table 2). Finally, rBmNPV-
hPRR was purified by 48-fold.
As an alternative column, Sephacryl S-1000 SF column
chromatography was used for rBmNPV-hPRR purifica-
tion. Sephacryl S-1000 SF is optimized for the purification
of DNA, viruses and spherical particles up to 400 nm and
its fraction range is from 5 × 105 to 1 × 108 Da. Larval
hemolymph was pretreated as mentioned above. Seven
Virus titer (A) and virus number (B) of hemolymph from silk- worm larvae infected with various titers of baculovirus Figure 2
Virus titer (A) and virus number (B) of hemolymph 
from silkworm larvae infected with various titers of 
baculovirus. Before injection into silkworm larvae, 2.38 × 
103, 2.38 × 105, 2.38 × 107 pfu/ml of baculovirus solution was 
prepared by dilution of hemolymph from rBmNPV-hPRR 
bacmid-injected silkworm larvae with PBS (pH 6.2). White 
and black bars in (A) and (B) indicate 4 and 5 days p.i., 
respectively.
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Purification of rBmNPV-hPRR from hemolymph by Superdex 200 10/300 GL column chromatography and Sephacryl S-1000 SF  column chromatography Figure 3
Purification of rBmNPV-hPRR from hemolymph by Superdex 200 10/300 GL column chromatography and 
Sephacryl S-1000 SF column chromatography. (A) and (C) Chromatogram of Superdex 200 10/300 GL and Sephacryl S-
1000 SF column chromatography and GP64 detection by Western blot using anti-Bmgp64 antibody. Solid and dotted lines indi-
cate absorbance at 280 and 254 nm, respectively. Numbers on GP64 bands indicate fraction numbers. (B) and (D) Baculovirus 
number as present in each fraction of Superdex 200 10/300 GL and Sephacryl S-1000 SF column chromatography. (E) SDS-
PAGE analysis of proteins of each purified rBmNPV-hPRR fraction stained with CBB. Lane 1, hemolymph; lane 2, rBmNPV-
hPRR purified by Superdex 200 10/300 GL column chromatography; lane 3, rBmNPV-hPRR purified by Sephacryl S-1000 col-
umn chromatography; lane 4, rBmNPV-hPRR purified from Bm5 cell culture supernatant.
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ml of larval hemolymph (2.91 × 108 pfu/ml) was applied
to Sephacryl S-1000 SF column equilibrated with PBS.
Elution was performed by PBS and every 5 ml fraction was
collected as shown in Figure 3C. The first peak was
observed between 100 and 130 ml, followed by the
increasing second peak from elution volume of 200 ml.
GP64 was detected in the first peak (Fraction 21–23 in Fig-
ure 3C). The maximum baculovirus number was 3.21 ×
108 pfu in the fraction 22 (Figure 3D), and total number
of rBmNPV-hPRR recovered was 7.21 × 108 pfu. Recovery
yield of rBmNPV-hPRR was 35%, and decreased to 4% by
concentration via ultracentrifugation (Table 2). rBmNPV-
hPRR was finally purified by 183-fold using Sephacryl S-
1000 SF column chromatography. Transfiguracion et al.
[13] reported that low recovery using Sephacryl S-1000 SF
column chromatography and concentration by ultracen-
trifugation would be improved by the treatment of hemo-
lymph with Benzonase and buffer exchange during the
purification steps involved.
Proteins of rBmNPV-hPRR purified by Superdex 200 was
analyzed by SDS-PAGE which showed two bands between
60 and 80 kDa similar to hemolymph (lane 2 in Figure
3E). However, when Sephacryl S-1000 was used, these
two bands disappeared (lane 3 in Figure 3E), resembling
the pattern of protein bands found for rBmNPV-hPRR
purified from Bm5 cell culture supernatant. Major pro-
teins between 60 and 80 kDa, present in larval hemol-
ymph, was removed completely. This shows that
Sephacryl S-1000 holds a good performance in purifica-
tion of the rBmNPV-hPRR from silkworm larval hemol-
ymph directly, without any contaminants.
Purification efficiency of baculovirus from larval 
hemolymph harvested at different postinjection time
The baculovirus-infected silkworm larvae became black in
color at 4 days p.i. and displayed wandering characteris-
tics from 4 – 5 days p.i.. After this stage, they began to die.
The larval hemolymph was harvested from rBmNPV-
hPRR-injected silkworm larvae (around 25 in number) at
4, 4.5 and 5 days p.i. It was then centrifuged, and filtered
by 0.2 μm membrane filter to remove insoluble materials.
The final harvested volume at 4, 4.5 and 5 days p.i. was
16, 16, and 12 ml, respectively. rBmNPV-hPRR was puri-
fied from hemolymph corresponding to each day by
Sephacryl S-1000 SF column chromatography (Table 3).
At 5 days p.i., the baculovirus concentration was 8.29 ×
108 pfu/ml and protein concentration was 43.2 mg/ml of
hemolymph, which were the highest among the three
hemolymph samples. At 5 days p.i., purified baculovirus
number (2.94 × 108 pfu) was also the highest, but purifi-
cation efficiency (39 fold) was lower than that (264 fold)
of hemolymph at 4 days p.i.. The number of rBmNPV-
hPRR/mg protein was 1.55 × 109 pfu/mg at 4 days p.i.,
which was the purest among the three samples.
Table 2: Summary of purification of rBmNPV-hPRR from hemolymph by Superdex 200 10/300 GL and Sephacryl S-1000 SF column 
chromatography
Volume (ml) Titer (pfu/ml) Virus (pfu) Protein (mg/ml) Virus/Protein (pfu/mg) Recovery (%) Purification (fold)
Hemolymph 0.5 2.38E+08 1.19E+08 33.2 7.17E+06 100 1
Superdex 200 10/300 GL 2 6.05E+07 1.21E+08 0.21 2.88E+08 102 40
Concentrated virus 0.25 1.44E+08 3.60E+07 0.42 3.43E+08 30 48
Hemolymph 7 2.91E+08 2.04E+09 24.2 1.20E+07 100 1
Sephacryl S-1000 30 2.40E+07 7.21E+08 0.024 1.00E+09 35 83
Concentrated virus 0.5 1.60E+08 8.00E+07 0.073 2.19E+09 4 183
Table 3: Summary of baculovirus purification from hemolymph for 25 number of silkworm larvae harvested at different post-injection
Harvesting time (p.i.) Volume (ml) Titer (pfu/ml) Virus (pfu) Protein (mg/ml) Virus/protein (pfu/mg) Recovery (%) Purification (fold)
4d
Hemolymph 16 2.03E+08 3.25E+09 34.5 5.88E+06 100 1
Concentrated virus after 
Sephacryl
0.9 1.35E+08 1.22E+08 0.087 1.55E+09 4 264
4.5d
Hemolymph 16 4.22E+08 6.75E+09 34.9 1.21E+07 100 1
Concentrated virus after 
Sephacryl
0.9 9.96E+07 8.96E+07 0.237 4.20E+08 1 35
5d
Hemolymph 12 8.29E+08 9.95E+09 43.2 1.91E+07 100 1
Concentrated virus after 
Sephacryl
0.6 4.90E+08 2.94E+08 0.659 7.43E+08 3 39BMC Biotechnology 2009, 9:55 http://www.biomedcentral.com/1472-6750/9/55
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Analysis of rBmNPV-hPRR purified from hemolymph at 4 
and 5 days post-injection
To confirm the expression of hPRR on the surface of rBm-
NPV-hPRR, Western blot was carried out. The hPRR was
observed in purified rBmNPV-hPRR at 5 days, but not at 4
days (Figure 4). Forty two nanograms of hPRR, by densit-
ometry analysis, were obtained from 1 μg of purified rBm-
NPV-hPRR at 5 days p.i.. Quantity of rBmNPV-hPRR per
mg of protein decreased at 5 days compared to 4 days
because of an increase of protein concentration in purified
rBmNPV-hPRR at 5 days.
To analyze proteins in each purified rBmNPV-hPRR, SDS-
PAGE was performed and the gel was stained with CBB
(Figure 5). Pattern of protein bands was not different
between purified rBmNPV-hPRR at 4 days and 5 days p.i..
This suggests that an increase of protein concentration in
purified rBmNPV-hPRR at 5 days p.i. was not due to the
contamination of intracellular proteins in purified rBm-
NPV-hPRR. Ratio of GP64 (d), a major envelope protein,
to VP39 (f), a major nucleocapsid protein increased at 5
days p.i. (Table 4). Two protein bands (e and g) also
increased likely with an increase in GP64. It was reported
that these two bands, e and g, is the budded baculovirus-
specific proteins [21]. This indicates that envelope pro-
teins increase in rBmNPV-hPRR as infection time passes.
When the purified rBmNPV-hPRR particles from hemol-
ymph were observed using transmission electron micros-
Western blot analysis of hPRR in each purified rBmNPV- hPRR from hemolymph by Sephacryl S-1000 column chroma- tography Figure 4
Western blot analysis of hPRR in each purified rBm-
NPV-hPRR from hemolymph by Sephacryl S-1000 
column chromatography. hPRR of purified rBmNPV-
hPRR was detected on reduced condition in Western blot-
ting with mouse anti-FLAG M2 antibody, because the hPRR is 
a native form with FLAG peptide sequence. Lane 1, purified 
rBmNPV-hPRR at 4 days p.i.; lane 2, purified rBmNPV-hPRR 
at 5 days p.i..
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SDS-PAGE analysis of proteins in purified rBmNPV-hPRR at  4 and 5 days by CBB stain Figure 5
SDS-PAGE analysis of proteins in purified rBmNPV-
hPRR at 4 and 5 days by CBB stain. Envelope and nucle-
ocapsid proteins of purified rBmNPV-hPRR were separated 
by SDS-PAGE using 12% polyacrylamide. Lane 1, purified 
rBmNPV-hPRR at 4 days (1.1 μg of protein); lane 2, purified 
rBmNPV-hPRR at 5 days (1.6 μg of protein). a-g denotes 
main protein bands of rBmNPV-hPRR.
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copy (TEM), it contained aberrant sized particles (small
and thick particles) at 5 days p.i. compared to that of 4
days p.i. (Figure 6A). rBmNPV-hPRR particles enclosed
with thick envelopes also appeared. When thin-section
TEM was performed, thick envelopes around rBmNPV-
hPRR particles were observed too (Figure 6B). Moreover,
envelope proteins in rBmNPV-hPRR from hemolymph
were increased at 5 days p.i.. This reveals that low purifi-
cation efficiency of rBmNPV-hPRR from hemolymph at 5
days p.i. might be due to thick envelope proteins formed
around the rBmNPV-hPRR particles.
Discussion
Q-PCR is applicable for the rapid titer determination of
viruses like adenoviruses, retroviruses and AcMNPV
[19,22-24]. Especially in the case of AcMNPV, SYBR Green
I was adopted for Q-PCR and a correlation between titers
determined by end-point dilution and Q-PCR has been
observed. However, in the case of BmNPV titer determina-
tion, the method was dependent only on conventional
plaque assay and end-point dilution method only, until
now. In this study, we established the Q-PCR titer deter-
mination method for BmNPV. The melting point of
amplified fragment from BmNPV DNA was 82°C, but the
melting point of amplified fragment from AcMNPV DNA
was approximately 86°C. Identity in DNA sequence
between the two fragments is 95.8%. The difference
between two melting points is supposed to result from the
difference between the nucleotide sequences of the
respective two fragments.
The baculovirus number from the hemolymph of a
BmNPV bacmid-injected silkworm larva was 2.8 × 104
times higher than that of transfection solution in spite of
usage of the same amount of BmNPV bacmid. Baculovirus
infection was not observed using transfection solution as
baculovirus solution, indicating that it is difficult for the
amount of rBmNPV-hPRR in transfection solution to
infect Bm5 cells in normal condition due to a very small
amount of baculovirus titer. This implies that many
amplification steps are a prerequisite towards a successful
infection of Bm5 cells. It takes at least a month to amplify
baculoviruses up to a sufficient titer. Using hemolymph as
a baculovirus stock to increase baculovirus titer can thus
save time, cost and labor. In this report, the maximum
baculovirus titer of hemolymph from BmNPV-infected
silkworm larvae was found to be 4.50 × 109 pfu/ml.
Sephacryl S-1000 SF column is more appropriate for the
purification of BmNPV from larval hemolymph than
Superdex 200 10/300 GL column, because of its efficiency
in removal of contaminant proteins. In the case of purifi-
cation of Lily symptomless virus from fresh infected-tis-
sues of Lanzhou lily, Sephadex-200 HR was superior to
Sephacryl S-1000 method [25]. In this study, Sephadex-
200 HR also was found to be superior to Sephacryl S-1000
SF column chromatography in the baculovirus recovery,
but purification yield was one-third to that with Sephacryl
S-1000 SF column chromatography. Turkey coronavirus
was also purified by Sephacryl S-1000 SF column chroma-
tography from intestines and intestinal contents of
infected turkey embryos [26].
Several researchers have reported that BmNPV was puri-
fied from silkworm pupae by sucrose gradient centrifuga-
tion [27,28]. In the case of purification of BmNPV from
silkworm larval hemolymph, this paper gives the first
report using SEC. Quantity of rBmNPV-hPRR per mg of
protein decreased at 5 days p.i. compared to 4 days p.i..
However, protein-band pattern in purified rBmNPV-hPRR
at 4 and 5 days p.i. was similar; this denotes that there was
no contamination in purified rBmNPV-hPRR at 5 days
p.i.. But proteins of which rBmNPV-hPRR is composed of
may increase at 5 days p.i.. In fact, purified rBmNPV-hPRR
from hemolymph at 5 days p.i. contained more envelope
Shapes of purified rBmNPV-hPRR from larval hemolymph at  4 and 5 days p Figure 6
Shapes of purified rBmNPV-hPRR from larval hemol-
ymph at 4 and 5 days p.i. (A) TEMs of purified rBmNPV-
hPRR from hemolymph at 4 and 5 days p.i.. (B) Thin-section 
TEM of purified rBmNPV-hPRR from hemolymph at 5 days 
p.i..
(A)
(B)
200 nm
200 nm
4 days P.I.T. 5 days P.I.T.
Envelope
Nucleocapsid
Table 4: Densitometry analysis of each protein band in purified 
rBmNPV-hPRR at 4 and 5 days p.i. as shown in Figure 4
Harvesting time (p.i.) a/f b/f c/f d/f e/f f/f g/f
4 d 0.28 0.34 0.55 0.46 0.32 1 0.4
5 d 0.36 0.41 0.54 0.88 0.55 1 0.7
5 d/4 d 1.29 1.2 0.98 1.91 1.66 100 1.75BMC Biotechnology 2009, 9:55 http://www.biomedcentral.com/1472-6750/9/55
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proteins than that at 4 days p.i.. Moreover, hPRR which is
expressed in the envelope was observed at 5 days p.i., but
not 4 days p.i. Electron micrographs revealed that purified
rBmNPV-hPRR from hemolymph at 5 days p.i. possessed
thick envelopes, resulting in low purification efficiency of
rBmNPV-hPRR from hemolymph at 5 days p.i.. The
increase of envelope proteins in rBmNPV-hPRR of larval
hemolymph at 5 days p.i. was caused by thick envelopes
around rBmNPV-hPRR particles. Besides, it was previ-
ously reported that increase of mutant virus, defective
interfering baculoviruses (DIs), which lacks considerable
parts of its genome, was observed during serial passage of
AcMNPV in insect cells [29,30] and the large deletion of
its genome may be caused by several hetero- and homol-
ogous recombination mechanism [31]. DIs of BmNPV
was also found in cultured cells [32]. DIs might not be
detected by Q-PCR titer measurement method because of
the large deletion of its genome, probably the loss of ie-1
gene. It is suggested that DIs, which missed ie-1  gene,
increased in hemolymph during BmNPV infection and
therefore quantity of rBmNPV-hPRR per mg of protein
decreased at 5 day p.i.
Conclusion
The applicability of Q-PCR for BmNPV titer determina-
tion was found successful in the current study. Hemol-
ymph from silkworm larva infected by rBmNPV
(rBmNPV-hPRR) contains its titer in higher amount of
BmNPV, even though 1:105  diluted hemolymph was
injected to silkworm larva. Moreover, a higher titer of
rBmNPV-hPRR solution (4.50 × 109 pfu/ml) was obtained
from silkworm larval hemolymph. Purification of rBm-
NPV-hPRR from silkworm larval hemolymph was success-
fully implemented by Sephacryl S-1000 SF column
chromatography. The purified rBmNPV-hPRR showed
that the hPRR was displayed on the surface of rBmNPV.
This system allows a large-scale production and purifica-
tion of rBmNPV displaying recombinant protein, which
can be applicable for the functional analysis of receptors,
drug delivery system and vaccines against infectious
viruses and protozoa.
Methods
Insects
For silkworm infection, hemolymph or transfection solu-
tion of recombinant baculovirus-infected larvae was
injected into the first day of fifth instar larvae (Ehime San-
syu Co. Ltd., Ehime, Japan). After 3–5 days, silkworm lar-
val hemolymph was collected.
Construction of rBmNPV-hPRR bacmid
hPRR is a native form with FLAG peptide sequence behind
its signal peptide sequence, as reported previously [33].
hPRR  was amplified by PCR using prorenin-F (CA
CCATGGCTGTGTTTGTCGTGCTCCTGGCGTTGGTGGC
GGGTGTTTTGGGGGACTACAAGGACGACGACGAC AA
G) and prorenin-R (ACGGAATTCTAATCCATTCGAA TCT-
TCT G G) primers and inserted into pENTR/D-TOPO by
TOPO cloning method (Invitrogen, Carlsbad, CA, USA).
The details of DNA amplification cycle are: 95°C for 3
min for one cycle, followed by 30 cycles of amplification
with denaturation at 95°C for 30 s, annealing at 50°C for
30 s and the final extension at 72°C for 2 min. rBmNPV-
hPRR bacmid was constructed using Escherichia coli
BmDH10Bac [34], which was transfected in Bm5 cells.
After 6 days cultivation, rBmNPV-hPRR bacmid was har-
vested.
Titer determination of BmNPV particles by quantitative 
real-time PCR
Baculoviral DNA was extracted by High Pure Viral Nucleic
Acid Kit (Roche Diagnostics K. K., Tokyo, Japan) accord-
ing to the manufacturer's protocol. The titration assay
using Q-PCR was performed by Mx3000P system (Strata-
gene, La Jolla, CA, USA). The ie-1-specific primers, Bmie-
1-F (CCCGTAACGGACCTTGTGCTT) and Bmie-1-R
(TTATCGAGATTTATTTACATACAACAAG) were used. For
the Q-PCR assays, FullVelocity SYBR Green QPCR Master
Mix (Stratagene) was used. A 6 μl of extracted baculoviral
DNA was used for Q-PCR in a 25 μl of final reaction mix-
ture containing 12.5 μl of 2 × FullVelocity SYBR Green
QPCR master mix, 1:500-diluted reference dye, and 0.1
μM Bmie-1-F and Bmie-1-R primers. Program for DNA
amplification cycle was: 95°C for 30 s for one cycle, fol-
lowed by 80 cycles of amplification protocol: denatura-
tion at 95°C for 10 s, annealing and extension at 60°C for
30 s. PCR amplification and melting curves were analyzed
by MxPro software (Stratagene).
Production and purification of BmNPV from larval 
hemolymph by Superdex 200 10/300 GL or Sephacryl S-
1000 SF column chromatography
Production of rBmNPV-hPRR in silkworm larvae was per-
formed by injecting 30 μl of 100-fold phosphate buffered
saline (PBS)-diluted hemolymph into silkworm larvae at
second day of fifth instar followed by breeding for 4–5
days. Hemolymph from BmNPV-infected silkworm larvae
was centrifuged at 20000 × g for 10 min. The collected
supernatant filtered with 0.2 μm filter is then applied to
Superdex 200 10/300 GL column (1.0 × 24 cm, GE
Healthcare UK Ltd., Buckinghamshire HP7 9NA, Eng-
land) or Sephacryl S-1000 SF column (2.6 × 52 cm, GE
Healthcare UK Ltd.) equilibrated with PBS (pH 6.2). Elu-
tion was performed at 4°C chromate-chamber and moni-
tored by absorbance at 280 and 254 nm. Every 0.5 or 5 ml
of fraction was collected in the case of Superdex 200 10/
300 GL column or Sephacryl S-1000 SF column. Fractions
containing BmNPV particles were pooled and then were
concentrated by ultracentrifugation at 114000 × g with
25% sucrose cushion (25% sucrose in 5 mM NaCl and 10
mM EDTA). Particles were suspended with a small vol-
ume of PBS (pH 6.2).BMC Biotechnology 2009, 9:55 http://www.biomedcentral.com/1472-6750/9/55
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SDS-PAGE and Western blot
Proteins were separated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) using 12%
polyacrylamide and subjected to Western blot. Under the
non-reducing condition, samples were mixed with sample
buffer lacking β-mercaptoethanol and boiled. Following
it, the proteins were blotted onto a polyvinylidene fluo-
ride (PVDF) membrane using Mini Trans-Blot Electro-
phoretic Transfer Cell (Bio-Rad, Hercules, CA, USA). After
being blocked in 5% skim milk in Tris-buffered saline
containing 0.1% Tween 20 (TBST), the membrane was
incubated in either 1:10000 diluted mouse anti-FLAG M2
antibody (Sigma-Aldrich, St. Louis, MO, USA) or 1:4000
diluted rabbit anti-Bmgp64 polyclonal antibody for 1
hour. The membrane was washed with TBST, and then
incubated in 1:20,000 diluted anti-mouse or anti-rabbit
IgG antibody labeled with horseradish peroxidase for 1
hour. Detection was performed using ECL Plus Western
blotting reagent (GE Healthcare UK Ltd.). Specific bands
were detected using a Fluor-S/MAX multi-imager (Bio-
Rad). Bands on SDS-PAGE gels were analyzed by Quantity
One 1-D analysis software (Bio-Rad).
Transmission electron microscopy (TEM)
BmNPV particles were fixed with a mixture of 2% parafor-
maldehyde and 2% glutaraledehyde in 0.1 M cacodylate
buffer, pH 7.4 and postfixed in 1% osmium tetroxide in
the same buffer. After further washes with the above
buffer, the specimens were collected and embedded in
agarose. The agarose blocks were dehydrated in ethanol
and embedded in an Epon/Araldite mixture. The ultrathin
sections were stained with uranyl acetate and lead citrate,
and then examined with a Hitachi H7500 electron micro-
scope at 80 kV.
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